Insulet Omnipod recall listed as Class I by FDA
Seeking Alpha ·
A recall of certain lots of Insulet's ( PODD ) Omnipod insulin pump system, first identified in March, has been deemed a Class I recall by the US FDA, the most serious type. Impacted products are the Omnipod 5, Omnipod DASH, and Omnipod Eros.
DYAX Investor Sentiment
Bullish (Long) 58% · Bearish (Short) 42%
419 participants
Related News
- Navient hit by cyber attack exposing sensitive customer details
- Meta CEO says agent development not accelerating as expected: report
- U.S. drilling rigs rise by 7 for 10th gain in 11 weeks, Baker Hughes says
- 5 Artificial Intelligence (AI) Stocks to Load Up On in July
- Navient reports data breach involving third-party law firm
- Update: US Equity Indexes Mixed as Weak Jobs Data Trigger Rotation Out of Growth Stocks